RA
ULBI icon

Rise Advisors’s Ultralife ULBI Stock Holding History

Rise Advisors’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$341 – 1347
2025
Q3 		$341 Hold
50
– – ﹤0.01% 1455
2025
Q2 		$449 Hold
50
– – ﹤0.01% 1440
2025
Q1 		$269 Hold
50
– – ﹤0.01% 1428
2024
Q4 		$373 Sell
50
-50
-50% -$411 ﹤0.01% 1106
2024
Q3 		$904 Hold
100
– – ﹤0.01% 1167
2024
Q2 		$1.06K Hold
100
– – ﹤0.01% 1160
2024
Q1 		$881 Hold
100
– – ﹤0.01% 1187
2023
Q4 		$682 Hold
100
– – ﹤0.01% 547
2023
Q3 		$976 Hold
100
– – ﹤0.01% 537
2023
Q2 		$484 Hold
100
– – ﹤0.01% 620
2023
Q1 		$402 Hold
100
– – ﹤0.01% 749
2022
Q4 		$386 Hold
100
– – ﹤0.01% 723
2022
Q3 		$0 Hold
100
– – ﹤0.01% 749
2022
Q2 		$0 Hold
100
– – ﹤0.01% 738
2022
Q1 		$1K Hold
100
– – ﹤0.01% 642
2021
Q4 		$604 Buy
+100
New +$614 ﹤0.01% 619

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Rise Advisors's ULBI Position: Q4 2025 in Review

Rise Advisors sold out of Ultralife (ULBI) in Q4 2025, closing a stake of 50 shares — an estimated $341 sold.

Rise Advisors first reported a position in ULBI in Q4 2021 and held it in 16 quarters. The position peaked at $1.06K in Q2 2024. 60 funds tracked by Wall St. Rank hold ULBI as of Q4 2025.

  • Rise Advisors reported no remaining Ultralife position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 50 Ultralife shares in Q4 2025, an estimated $341.
  • Rise Advisors first reported a position in Ultralife in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Ultralife position peaked at $1.06K in Q2 2024.
  • 60 funds tracked by Wall St. Rank held Ultralife as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.